Cns Pharmaceuticals Inc’s filing revealed that its Chief Executive Officer Climaco John M acquired Company’s shares for reported $50000.0 on Feb 01 ’24. In the deal valued at $0.30 per share,166,666 shares were bought. As a result of this transaction, Climaco John M now holds 215,676 shares worth roughly $45291.96.
Then, Downs Christopher bought 66,666 shares, generating $20,000 in total proceeds. Upon buying the shares at $0.30, the Chief Financial Officer now owns 103,438 shares.
Before that, Evans Carl Anthony bought 33,333 shares. Cns Pharmaceuticals Inc shares valued at $10,000 were divested by the Director at a price of $0.30 per share. As a result of the transaction, Evans Carl Anthony now holds 33,458 shares, worth roughly $7026.179999999999.
Ladenburg Thalmann downgraded its Cns Pharmaceuticals Inc [CNSP] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating.
Price Performance Review of CNSP
On Tuesday, Cns Pharmaceuticals Inc [NASDAQ:CNSP] saw its stock fall -14.58% to $0.21. Over the last five days, the stock has lost -8.95%. Cns Pharmaceuticals Inc shares have fallen nearly -83.58% since the year began. Nevertheless, the stocks have fallen -91.13% over the past one year. While a 52-week high of $4.40 was reached on 01/02/24, a 52-week low of $0.22 was recorded on 04/16/24. SMA at 50 days reached $0.3141, while 200 days put it at $1.2955. A total of 0.36 million shares were traded, compared to the trading of 0.12 million shares in the previous session.
Levels Of Support And Resistance For CNSP Stock
The 24-hour chart illustrates a support level at 0.1966, which if violated will result in even more drops to 0.1846. On the upside, there is a resistance level at 0.2314. A further resistance level may holdings at 0.2542. The Relative Strength Index (RSI) on the 14-day chart is 27.23, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0432, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.45%. Stochastics %K at 9.50% indicates the stock is a buying.
